SCHEMBL7776236

SCHEMBL7776236

Nc1nc(O)c(Br)c(-c2cccc(F)c2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.55
ADORA1 P30542 5/20 0.52
ADORA2B P29275 2/20 0.52
CHUK O15111 1/20 0.45
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
DPP4 P27487 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
ESR2 Q92731 1/20 0.41
TRPM8 Q7Z2W7 3/20 0.39
PIK3CD O00329 1/20 0.38
PIK3C2B O00750 1/20 0.38
PDXK O00764 1/20 0.38
GAK O14976 1/20 0.38
MAP3K7 O43318 1/20 0.38
RIPK2 O43353 1/20 0.38
PIP5K1C O60331 1/20 0.38
STK16 O75716 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7774800 0.82 ADORA2A (0.56) ADORA2AADORA1ADORA2BDPP4MAP4K4
SCHEMBL7774460 0.82 ADORA2A (0.55) ADORA2AADORA1ADORA2BCHUKKDM4E
SCHEMBL7777639 0.82 ADORA2A (0.55) ADORA2AADORA1ADORA2BCHUKKDM4E
SCHEMBL10981072 0.81 ADORA2A (0.56) ADORA2AADORA1MAPT
SCHEMBL9133539 0.81 ADORA2A (0.49) ADORA2AADORA1ADORA2BCHUKKDM4E
Bropirimine SCHEMBL4321472 0.80 ADORA2A (0.50) ADORA2AADORA1ADORA2BCSNK1A1PIK3CG
SCHEMBL7774476 0.78 ADORA2A (0.58) ADORA2AADORA1ADORA2BMAPTDPP4
SCHEMBL17667854 0.76 ADORA2A (0.62) ADORA2AADORA1ADORA2BCHUKKDM4E
SCHEMBL18748036 0.76 ADORA2A (0.57) ADORA2AADORA1ADORA2BCHUKKDM4E
SCHEMBL9132123 0.76 NPC1 (0.46) ADORA2AADORA1ADORA2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2001505911-A 2001-05-08 JP claimed
EP-0948331-A2 METHOD FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1999-10-13 EP claimed
WO-1998025596-A2 USE OF A 6-ARYL PYRIMIDINE COMPOUND FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1998-06-18 WO claimed
US-5434157-A Active against herpes, hepatitis, papovavirus THE UPJOHN COMPANY (US) 1995-07-18 US claimed
EP-0948331-A2 METHOD FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1999-10-13 EP disclosed
WO-1998025596-A2 USE OF A 6-ARYL PYRIMIDINE COMPOUND FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1998-06-18 WO disclosed
US-5554617-A Method for treating cancer with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1996-09-10 US disclosed
US-5434157-A Active against herpes, hepatitis, papovavirus THE UPJOHN COMPANY (US) 1995-07-18 US disclosed
US-5002951-A 2-amino-5-halo-4-pyrimidinol for bactericides and antiprotozoa agent THE UPJOHN COMPANY (US) 1991-03-26 US disclosed
US-4665077-A IMMUNOREGULATORY AGENTS THE UPJOHN COMPANY (US) 1987-05-12 US disclosed
US-4619933-A 6-aryl pyrimidines for treating aplastic anemia THE UPJOHN COMPANY (US) 1986-10-28 US disclosed
US-4543248-A Method for immunoregulation with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-09-24 US disclosed
US-4507302-A Method for treating arthritis with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-03-26 US disclosed